Health Catalyst CEO buys 25K shares at $1.76

Health Catalyst CEO Simeon Kohl reports direct ownership of 25,000 common shares acquired in an open market purchase.

Rhea-AI Filing Summary

Health Catalyst, Inc. (HCAT) disclosed that Simeon Kohl, its Chief Executive Officer and a director, beneficially owns 25,000 shares of common stock. According to the accompanying footnote, Kohl acquired an aggregate of 25,000 shares on September 11, 2026 through an open market purchase at a weighted average price of $1.76427 per share, and these shares are now held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kohl Simeon

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Common Stock F1	--	--	--

Holdings After Transaction: Common Stock — 25,000 shares (Direct)

Footnotes (1)

1. F1. On September 11, 2026, Reporting Person acquired an aggregate of 25,000 shares of the Issuer's common stock through open market purchase with a weighted average price of $1.76427 per share.

Key Figures

Common shares owned: 25,000 shares Acquisition date: September 11, 2026 Weighted average purchase price: $1.76427 per share

3 metrics

Common shares owned 25,000 shares Directly owned by Simeon Kohl following the reported activity

Acquisition date September 11, 2026 Date Kohl acquired 25,000 HCAT shares in open market purchase

Weighted average purchase price $1.76427 per share Price for Kohl’s September 11, 2026 open market purchase

Key Terms

Form 3, open market purchase, weighted average price

3 terms

Form 3 regulatory

"HCAT disclosed Simeon Kohl’s ownership on a Form 3 as an officer-director"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

open market purchase financial

"Kohl acquired 25,000 shares through open market purchase on September 11, 2026"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

weighted average price financial

"The filing reports a weighted average price of $1.76427 per share"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HCAT disclose about Simeon Kohl’s holdings in this Form 3?

HCAT reported that Chief Executive Officer and director Simeon Kohl beneficially owns 25,000 shares of common stock, held directly. A footnote explains that these shares were acquired in a single aggregated open market purchase on September 11, 2026 at a weighted average price of $1.76427 per share.

How many Health Catalyst (HCAT) shares does Simeon Kohl own after the reported transaction?

After the reported activity, Simeon Kohl holds 25,000 shares of HCAT common stock directly. This amount reflects the aggregate shares acquired through the September 11, 2026 open market purchase described in the filing’s footnote.

At what price did Simeon Kohl acquire Health Catalyst (HCAT) shares?

The filing states that Simeon Kohl acquired an aggregate of 25,000 HCAT shares on September 11, 2026 through open market purchase at a weighted average price of $1.76427 per share, as disclosed in the footnote linked to his reported holdings.

Was Simeon Kohl’s Health Catalyst (HCAT) purchase an open market transaction?

Yes. The footnote specifies that on September 11, 2026, Simeon Kohl acquired 25,000 shares of Health Catalyst common stock through an open market purchase, at a weighted average price of $1.76427 per share, and these shares are now reported as directly owned.

Does the Form 3 show any derivative securities for Simeon Kohl in HCAT?

No. The Form 3 data lists only common stock holdings for Simeon Kohl, totaling 25,000 shares held directly, and the derivative securities section is empty, indicating no derivative positions are reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:53 PM Accepted by SEC EDGAR 09/16/2026 - 04:51 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kohl Simeon

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/14/2026

3. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	25,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On September 11, 2026, Reporting Person acquired an aggregate of 25,000 shares of the Issuer's common stock through open market purchase with a weighted average price of $1.76427 per share.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)